Connor, Clark & Lunn Investment Management (CC&L)
ATRA icon

Connor, Clark & Lunn Investment Management (CC&L)’s Atara Biotherapeutics ATRA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ATRA Stock Details ATRA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$189K Buy
2022
Q4 		– Sell
2022
Q3 		$149K Sell
2022
Q2 		$817K Buy
2022
Q1 		$426K Buy
2021
Q4 		$291K Buy
2021
Q3 		$286K Buy
2020
Q2 		– Sell
2020
Q1 		$111K Buy